VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
A 5-year Study to Compare the Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-naïve Patients With Type 2 Diabetes Mellitus
Sponsor: Novartis Pharmaceuticals
This PHASE4 trial investigates Type 2 Diabetes Mellitus and is currently completed. Novartis Pharmaceuticals leads this study, which shows 27 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
27 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 22 earlier versions
-
May 2020 — Oct 2020 [monthly]
Completed PHASE4
-
Mar 2020 — May 2020 [monthly]
Completed PHASE4
-
Oct 2019 — Mar 2020 [monthly]
Completed PHASE4
-
Sep 2019 — Oct 2019 [monthly]
Completed PHASE4
-
Jul 2019 — Sep 2019 [monthly]
Completed PHASE4
-
Jun 2019 — Jul 2019 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE4
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE4
-
Mar 2019 — Apr 2019 [monthly]
Active Not Recruiting PHASE4
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE4
-
Jan 2019 — Feb 2019 [monthly]
Active Not Recruiting PHASE4
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE4
-
Nov 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE4
-
Oct 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE4
-
Sep 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE4
-
Jul 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Dec 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE4
-
Sep 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE4
-
Mar 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Mar 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Novartis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adana, Turkey (Türkiye), Aguascalientes, Mexico, Alberton, South Africa, Antalya, Turkey (Türkiye), Arenzano, Italy, Arequipa, Peru, Aschaffenburg, Germany, Bangalore, India, Banská Bystrica, Slovakia, Baranquilla, Colombia and 164 more location s